Aura Biosciences Statistics
Total Valuation
AURA has a market cap or net worth of $289.30 million. The enterprise value is $156.97 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURA has 50.23 million shares outstanding. The number of shares has increased by 25.32% in one year.
| Current Share Class | 50.23M |
| Shares Outstanding | 50.23M |
| Shares Change (YoY) | +25.32% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 1.69% |
| Owned by Institutions (%) | 47.61% |
| Float | 28.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.12.
| Current Ratio | 10.77 |
| Quick Ratio | 10.13 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.01% and return on invested capital (ROIC) is -28.87%.
| Return on Equity (ROE) | -46.01% |
| Return on Assets (ROA) | -27.46% |
| Return on Invested Capital (ROIC) | -28.87% |
| Return on Capital Employed (ROCE) | -57.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$797,422 |
| Employee Count | 109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AURA has paid $112,000 in taxes.
| Income Tax | 112,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.34% in the last 52 weeks. The beta is 0.43, so AURA's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -18.34% |
| 50-Day Moving Average | 6.73 |
| 200-Day Moving Average | 8.32 |
| Relative Strength Index (RSI) | 45.52 |
| Average Volume (20 Days) | 452,044 |
Short Selling Information
The latest short interest is 1.42 million, so 2.82% of the outstanding shares have been sold short.
| Short Interest | 1.42M |
| Short Previous Month | 1.19M |
| Short % of Shares Out | 2.82% |
| Short % of Float | 4.90% |
| Short Ratio (days to cover) | 3.83 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -96.12M |
| Pretax Income | -80.50M |
| Net Income | -86.92M |
| EBITDA | -94.89M |
| EBIT | -96.12M |
| Earnings Per Share (EPS) | -$1.75 |
Full Income StatementBalance Sheet
The company has $151.09 million in cash and $18.77 million in debt, giving a net cash position of $132.33 million or $2.63 per share.
| Cash & Cash Equivalents | 151.09M |
| Total Debt | 18.77M |
| Net Cash | 132.33M |
| Net Cash Per Share | $2.63 |
| Equity (Book Value) | 151.97M |
| Book Value Per Share | 3.04 |
| Working Capital | 145.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$79.81 million and capital expenditures -$1.25 million, giving a free cash flow of -$81.06 million.
| Operating Cash Flow | -79.81M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | -81.06M |
| FCF Per Share | -$1.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |